Is Eyepoint Pharmaceuticals Inc (EYPT) Stock at the Top of the Biotechnology Industry?

A rating of 72 puts Eyepoint Pharmaceuticals Inc (EYPT) near the top of the Biotechnology industry according to InvestorsObserver. Eyepoint Pharmaceuticals Inc's score of 72 means it scores higher than 72% of stocks in the industry. Eyepoint Pharmaceuticals Inc also received an overall rating of 55, putting it above 55% of all stocks. Biotechnology is ranked 55 out of the 148 industries.

EYPT has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on EYPT!

See Full EYPT Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 55 means the stock is more attractive than 55 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Eyepoint Pharmaceuticals Inc Stock Today?

Eyepoint Pharmaceuticals Inc (EYPT) stock is trading at $7.81 as of 12:22 PM on Friday, Nov 3, a rise of $0.51, or 7.06% from the previous closing price of $7.29. The stock has traded between $7.40 and $7.81 so far today. Volume today is light. So far 269,179 shares have traded compared to average volume of 455,954 shares. Click Here to get the full Stock Report for Eyepoint Pharmaceuticals Inc stock.